NORFLITS 10 CR contains Norethisterone 10 mg Controlled Release, formulated for selected menstrual and abnormal uterine bleeding indications. Its CR formulation adds differentiation to a focused PCD Pharma Gynae portfolio.
Selected menstrual and abnormal uterine bleeding disorders.
It is designed to provide prolonged drug exposure.
Follow the prescribed schedule carefully. Inform the physician about pregnancy, unexplained vaginal bleeding, liver disease or thrombotic history.
Nausea, headache, breast tenderness, bloating, mood changes and irregular bleeding may occur.
NORFLITS 10 CR: Norethisterone modifies endometrial activity through progesterone-receptor action, while the controlled-release formulation provides prolonged drug exposure.
